Molecular epidemiological characteristics of newly diagnosed HIV-1 cases in Fujian Province in 2020
OBJECTIVE: To investigate the HIV-1 genotype and distribution of newly diagnosed HIV-1 cases in Fujian Province in 2020, so as to provide insights into formulation of the precise AIDS control strategy in the province.
METHODS: Newly diagnosed HIV-1 cases without antiretroviral therapy (excluding AIDS patients) were randomly sampled from each city of Fujian Province in 2020 at a proportion of 50% of the mean number of HIV-infected cases reported across 9 cities of Fujian Province during the past three years. Subjects' demographic and epidemiological data were collected and blood samples were collected. The HIV-1 pol gene was amplified using nested reverse-transcription PCR assay, and the gene sequences were used for HIV-1 genotyping and phylogenetic analysis. The gene sequences were uploaded to the HIV Drug Resistance Database (http://hivdb.stanford.edu) for genotypic drug resistance assays, and the scores and level of HIV drug resistance were estimated using the HIVDB Algorithm version 9.5.
RESULTS: A total of 1 043 newly diagnosed HIV-1 cases were reported in Fujian Province in 2020, and 936 gene sequences were successfully obtained following sequencing of blood samples. There were 9 HIV-1 genotypes characterized in blood samples from 936 newly diagnosed HIV-1 cases, with CRF07_BC (52.1%) and CRF01_AE (30.4%) as predominant subtypes, followed by CRF08_BC (4.9%), CRF55_01B (3.0%), subtype C (2.5%), subtype B (2.1%), CRF85_BC (1.7%), CRF59_01B (0.3%) and CRF65_CPX (0.1%), and unidentified subtypes were found in 26 blood samples. HIV-1 drug resistance was detected in 43 out of the 936 newly diagnosed HIV-1 cases, with 4.6% prevalence of HIV-1 drug resistance prior to therapy, and the highest drug resistance was found in the HIV CRF59_01B subtype, followed by in CRF08_BC, B, C, CRF01_AE, CRF07_BC and other subtypes, with a significant difference in the genotype-specific prevalence of HIV-1 drug resistance (χ2 = 45.002, P < 0.05).
CONCLUSIONS: There was a HIV-1 genotype diversity in Fujian Province in 2020, and emerging recombinant and drug-resistant HIV-1 strains were detected and spread across patients and regions. Monitoring of HIV-1 genotypes is recommended to be reinforced for timely understanding of the transmission and spread of novel recombinant and drug-resistant HIV-1 strains.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control - 35(2023), 6 vom: 01. Dez., Seite 583-589 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Xie, M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Drug resistance |
---|
Anmerkungen: |
Date Completed 29.02.2024 Date Revised 29.02.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.16250/j.32.1374.2023003 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36902947X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM36902947X | ||
003 | DE-627 | ||
005 | 20240229235329.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2023 xx |||||o 00| ||chi c | ||
024 | 7 | |a 10.16250/j.32.1374.2023003 |2 doi | |
028 | 5 | 2 | |a pubmed24n1311.xml |
035 | |a (DE-627)NLM36902947X | ||
035 | |a (NLM)38413019 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Xie, M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Molecular epidemiological characteristics of newly diagnosed HIV-1 cases in Fujian Province in 2020 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.02.2024 | ||
500 | |a Date Revised 29.02.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To investigate the HIV-1 genotype and distribution of newly diagnosed HIV-1 cases in Fujian Province in 2020, so as to provide insights into formulation of the precise AIDS control strategy in the province | ||
520 | |a METHODS: Newly diagnosed HIV-1 cases without antiretroviral therapy (excluding AIDS patients) were randomly sampled from each city of Fujian Province in 2020 at a proportion of 50% of the mean number of HIV-infected cases reported across 9 cities of Fujian Province during the past three years. Subjects' demographic and epidemiological data were collected and blood samples were collected. The HIV-1 pol gene was amplified using nested reverse-transcription PCR assay, and the gene sequences were used for HIV-1 genotyping and phylogenetic analysis. The gene sequences were uploaded to the HIV Drug Resistance Database (http://hivdb.stanford.edu) for genotypic drug resistance assays, and the scores and level of HIV drug resistance were estimated using the HIVDB Algorithm version 9.5 | ||
520 | |a RESULTS: A total of 1 043 newly diagnosed HIV-1 cases were reported in Fujian Province in 2020, and 936 gene sequences were successfully obtained following sequencing of blood samples. There were 9 HIV-1 genotypes characterized in blood samples from 936 newly diagnosed HIV-1 cases, with CRF07_BC (52.1%) and CRF01_AE (30.4%) as predominant subtypes, followed by CRF08_BC (4.9%), CRF55_01B (3.0%), subtype C (2.5%), subtype B (2.1%), CRF85_BC (1.7%), CRF59_01B (0.3%) and CRF65_CPX (0.1%), and unidentified subtypes were found in 26 blood samples. HIV-1 drug resistance was detected in 43 out of the 936 newly diagnosed HIV-1 cases, with 4.6% prevalence of HIV-1 drug resistance prior to therapy, and the highest drug resistance was found in the HIV CRF59_01B subtype, followed by in CRF08_BC, B, C, CRF01_AE, CRF07_BC and other subtypes, with a significant difference in the genotype-specific prevalence of HIV-1 drug resistance (χ2 = 45.002, P < 0.05) | ||
520 | |a CONCLUSIONS: There was a HIV-1 genotype diversity in Fujian Province in 2020, and emerging recombinant and drug-resistant HIV-1 strains were detected and spread across patients and regions. Monitoring of HIV-1 genotypes is recommended to be reinforced for timely understanding of the transmission and spread of novel recombinant and drug-resistant HIV-1 strains | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Drug resistance | |
650 | 4 | |a Fujian Province | |
650 | 4 | |a Genotype | |
650 | 4 | |a Human immunodeficiency virus | |
650 | 4 | |a Molecular characteristic | |
650 | 4 | |a Phylogenetic analysis | |
700 | 1 | |a Lin, L |e verfasserin |4 aut | |
700 | 1 | |a Wang, Z |e verfasserin |4 aut | |
700 | 1 | |a Qiu, Y |e verfasserin |4 aut | |
700 | 1 | |a Lu, X |e verfasserin |4 aut | |
700 | 1 | |a Zhang, C |e verfasserin |4 aut | |
700 | 1 | |a Wu, S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control |d 2011 |g 35(2023), 6 vom: 01. Dez., Seite 583-589 |w (DE-627)NLM215845749 |x 1005-6661 |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2023 |g number:6 |g day:01 |g month:12 |g pages:583-589 |
856 | 4 | 0 | |u http://dx.doi.org/10.16250/j.32.1374.2023003 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2023 |e 6 |b 01 |c 12 |h 583-589 |